BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 31493426)

  • 1. As the world turns, evolving lymphoma classifications-past, present and future.
    Swerdlow SH; Cook JR
    Hum Pathol; 2020 Jan; 95():55-77. PubMed ID: 31493426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoma classification and the tools of our trade: an introduction to the 2012 USCAP Long Course.
    Swerdlow SH
    Mod Pathol; 2013 Jan; 26 Suppl 1():S1-S14. PubMed ID: 23281432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the working formulation of non-Hodgkin's lymphoma with the Rappaport, Kiel, and Lukes & Collins classifications. Translational value and prognostic significance based on review of 658 patients treated at a single institution.
    Ersbøll J; Schultz HB; Hougaard P; Nissen NI; Hou-Jensen K
    Cancer; 1985 May; 55(10):2442-58. PubMed ID: 3986740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A critical analysis of the classifications of non-Hodgkin's lymphomas.
    Nathwani BN
    Cancer; 1979 Aug; 44(2):347-84. PubMed ID: 383253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance of the Kiel and Lukes-Collins classifications of non-Hodgkin's lymphomas.
    Lennert K; Collins RD; Lukes RJ
    Histopathology; 1983 Jul; 7(4):549-59. PubMed ID: 6604012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new functional interpretation of malignant lymphomas. The Lukes-Collins classification and its basis].
    Maurer R; Lukes RJ
    Schweiz Med Wochenschr; 1979 Jan; 109(3):76-86. PubMed ID: 310578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoma classification: the quiet after the storm.
    Pileri SA; Agostinelli C; Sabattini E; Bacci F; Sagramoso C; Pileri A; Falini B; Piccaluga PP
    Semin Diagn Pathol; 2011 May; 28(2):113-23. PubMed ID: 21842697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Introduction to the modern classifications of the non-Hodgkin malignant lymphomas (author's transl)].
    Heimann R; Van den Heule B
    Dermatologica; 1978; 157(6):345-56. PubMed ID: 309837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphomas of large cells.
    Staples WG; Gétaz EP
    S Afr Med J; 1977 Sep; 52(11):438-43. PubMed ID: 335536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Rappaport classification of non-Hodgkin's lymphomas: a closer look using other proposed classifications.
    Garvin AJ; Simon R; Young RC; DeVita VT; Berard CW
    Semin Oncol; 1980 Sep; 7(3):234-43. PubMed ID: 6998002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of classifications of malignant lymphoma from the viewpoint of history].
    Tobinai K
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2157-66. PubMed ID: 9881073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Lukes-Collins and Kiel classifications for non-Hodgkin lymphomas. A retrospective study considering both classifications and their relationships to stage, sex, age, and survival.
    Blanco G; Alavaikko M; Apaja-Sarkkinen M; Taskinen PJ
    Anticancer Res; 1986; 6(2):267-79. PubMed ID: 3707063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
    Meusers P; Brittinger G
    Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A clinico-pathological and immunological study of unfavourable non-Hodgkin lymphomas. Comparison of the Rappaport and Kiel classifications.
    Lindemalm C; Christensson B; Johansson B; Mellstedt H; Ost A; Biberfeld P
    Acta Pathol Microbiol Immunol Scand A; 1983 Nov; 91(6):435-43. PubMed ID: 6364692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathological correlation of the Kiel with the original Rappaport classification of malignant non-hodgkin lymphomas.
    Krüger GR; Grisar T; Lennert K; Schwarze EW; Brittinger G
    Blut; 1981 Sep; 43(3):167-81. PubMed ID: 7343013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of malignant lymphomas using three classifications and the working formulation. 482 cases with median follow-up of 11.9 years.
    Lieberman PH; Filippa DA; Straus DJ; Thaler HT; Cirrincione C; Clarkson BD
    Am J Med; 1986 Sep; 81(3):365-80. PubMed ID: 3752139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classifications of lymphoma; reflections of time and technology.
    Taylor CR; Hartsock RJ
    Virchows Arch; 2011 Jun; 458(6):637-48. PubMed ID: 21503765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concepts of lymphoma classification.
    Krüger GR
    J Dermatol Surg Oncol; 1984 Apr; 10(4):247-54. PubMed ID: 6707307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current status of the problem of malignant lymphoma (on the centenary of the theory of malignant lymphoma)].
    Shtern RD
    Arkh Patol; 1984; 46(12):13-20. PubMed ID: 6395833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The problem of classifying lymphomas: an orderly prescription for progress.
    Berard CW; Hutchison RE
    Ann Oncol; 1997; 8 Suppl 2():3-9. PubMed ID: 9209632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.